Neurologist explains new drug combination for patients with ALS
Interview with Upstate neurologist Jenny Meyer, MD
Read the full articleYou might also wanna read
Revolutionizing ALS Treatment: The Tofersen Breakthrough
Dr. Gordon Smith and Dr. Timothy Miller discuss compelling clinical data suggesting that ALS may be a treatable disease for a subset of pati
A Neurologist's Experience as a Patient with ALS
Dr. Gordon Smith talks with Dr. Ajay Sampat about his journey of being a neurologist and getting diagnosed with ALS at 36.
Continuum: Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases - Part 3
In part 3 of a 3-part series, Lauren Elman, MD, discusses her article, "Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases" from
Continuum: Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases - Part 2
In part 2 of a 3-part series, Lauren Elman, MD, discusses her article, "Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases" from
Continuum: Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases - Part 1
In part 1 of a 3-part series, Lauren Elman, MD, discusses her article, "Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases" from
Pouring cold water on ALS progression: novel drug shields neurons from damage
Original story from the University of Arizona (AZ, USA). An experimental drug that targets the TDP-43 protein offers hope for treating Amyot
Comments
Sign in to join the conversation.
No comments yet. Be the first.